Abstract: In accordance with the present invention, methods have been developed for the reduction of the chloride content of epoxy compound starting materials. Invention methods comprise fractionating an epoxy compound starting material into portions (e.g., fractions or cuts) having different chloride content relative to the epoxy compound starting material. Certain of these collected portions (i.e., the portions fractionated and collected after collection of the forecut and before discontinuation of the fractionation) contain substantially reduced chloride levels relative to the epoxy compound starting material.
Abstract: Process for manufacturing oxirane by reaction of an olefin with a peroxide compound in the presence of a catalyst and a solvent in at least two reactors arranged in series, each of which contains a portion of catalyst, according to which the peroxide compound is introduced only into the first reactor, the subsequent reactor(s) not being fed with fresh peroxide compound, but only with the peroxide compound which is present in the medium obtained from the preceding reactor and which was not consumed in this preceding reactor.
Abstract: This invention is to provide a novel taxol derivative useful as an antitumor compound having respective substituent groups, represented by the following formula (I) which can be orally administered
Abstract: Taxanes having a heterosubstituted acetate substituent at C(7), a hydroxy substituent at C(10), and a range of C(2), C(9), C(14), and side chain substituents.
Abstract: Compounds of the formula I
are suitable for producing pharmaceuticals for the prophylaxis and therapy of diseases in which high blood platelet aggregations occur.
Type:
Grant
Filed:
November 21, 2002
Date of Patent:
January 6, 2004
Assignee:
Aventis Pharma Deutschland GmbH
Inventors:
Michael Kurz, Matthias Herrmann, Luigi Toti, Laszlo Vertesy
Abstract: A process for preparing compounds of formula (I) comprising radical addition of RfI to 3-(allyloxy)methyl-3-alkyloxetane (1) wherein R is C1-3 alkyl and Rf is C1-18 linear or branched fluoroalkyl.
The compounds of formula (I) are useful as intermediates for preparing various fluorine-containing functional materials.
Abstract: In a process for reacting an organic compound with a hydroperoxide using at least one heterogeneous catalyst, both the pH and the temperate of the reaction medium are changed during the reaction
Type:
Grant
Filed:
February 1, 2002
Date of Patent:
January 6, 2004
Assignee:
BASF Aktiengesellschaft
Inventors:
Joaquim Henrique Teles, Alwin Rehfinger, Peter Bassler, Norbert Rieber, Anne Wenzel, Andreas Walch, Wolfgang Harder
Abstract: The invention described herein relates to a process for the catalytic epoxidation of olefins with hydrogen peroxide in a continuous flow reaction system, wherein a gaseous phase containing an olefin and a liquid phase containing the hydrogen peroxide is present in the reaction system and the gaseous phase flows in countercurrent to the liquid phase.
Abstract: An integrated process and apparatus for integrating an alkene derivative process, such as ethylene oxide process, with an ethylene process so that any ethylene entrapped in the purge stream of the alkene derivative process can be effectively recovered through the ethylene process portion of the integrated process.
Type:
Grant
Filed:
September 27, 2001
Date of Patent:
December 23, 2003
Assignee:
Praxair Technology, Inc.
Inventors:
Minish Mahendra Shah, M. Mushtaq Ahmed, Raymond Francis Drnevich
Abstract: Taxanes having a heterosubstituted acetate substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substituents.
Abstract: Taxanes having a carbonate substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substituents.
Abstract: The present invention describes novel nitrosated and/or nitrosylated taxanes, and novel compositions comprising at least one nitrosated and/or nitrosylated taxane, and, optionally, at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The present invention also provides novel compositions comprising at least one taxane and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The compounds and compositions of the present invention can also be bound to a matrix.
Type:
Grant
Filed:
June 22, 2001
Date of Patent:
December 2, 2003
Assignee:
NitroMed, Inc.
Inventors:
David S. Garvey, L. Gordon Letts, Chia-En Lin, Stewart K. Richardson, Tiansheng Wang
Abstract: A process for preparing N-acyl, N-sulfonyl and N-phosphoryl substituted isoserine esters in which a metal or an ammonium alkoxide is reacted with a &bgr;-lactam.
Abstract: In a process for preparing polyether alcohols by catalytic addition of at least two alkylene oxides onto H-functional initiator substances, at least one multimetal cyanide compound is used as catalyst and the addition of the alkylene oxides onto the initiator substance includes incorporation of at least one oxyalkylene block during whose formation at least two alkylene oxides are metered in together and the ratio of the alkylene oxides to one another in the mixture is changed during the joint introduction.
Type:
Grant
Filed:
May 21, 2002
Date of Patent:
November 25, 2003
Assignee:
BASF Aktiengesellschaft
Inventors:
Kathrin Harre, Gerd Höppner, Georg Heinrich Grosch, Stephan Bauer, Jürgen Winkler, Els Paredis, Reinhard Lorenz, Inge Rotermund
Abstract: Methods of preparing amino acid-substituted taxanes such as:
using selected blocked amino acids are disclosed. After coupling of the blocked amino acid to the taxane, deprotection is carried out with about an equimolar amount of a secondary amine thus substantially avoiding base-catalyzed hydrolysis of amino acid from the taxane. The preferred amino acid-taxanes are useful as intermediates in the production of polymer conjugated therapeutic compositions or as part of pharmaceutically acceptable formulations.
Abstract: The present invention relates to a process for the working up of a product stream from the epoxidation of olefins that contains olefin, olefin oxide, water-miscible organic solvent and water, by separating this product stream into an overhead product containing olefin, olefin oxide and organic solvent, and into a bottom product containing organic solvent and water, wherein the separation takes place in a pre-evaporator with at most 5 theoretical separation stages, and 20 to 60% of the total amount of organic solvent introduced with the product stream is removed with the overhead product and the residue remains in the bottom product, as well as a process for the epoxidation of olefins that includes this working up stage.
Type:
Grant
Filed:
October 4, 2002
Date of Patent:
November 11, 2003
Assignees:
Degussa AG, UHDE GmbH
Inventors:
Willi Hofen, Georg Thiele, Alexander Möller
Abstract: A process for producing propylene oxide comprising the following steps:
oxidation step: a step of obtaining isopropylbenzene hydroperoxide by oxidizing isopropylbenzene;
epoxidation step: a step of obtaining propylene oxide and cumyl alcohol by reacting propylene with isopropylbenzene hydroperoxide obtained in the oxidation step;
hydrogenolysis step: a step of obtaining isopropylbenzene by hydrogenolyzing cumyl alcohol obtained in the epoxidation step, and recycling this isopropylbenzene to the oxidation step as a raw material of the oxidation step; and
organic acid removal step: a step of removing an organic acid out of the system in at least one point in said steps or between said steps.
Abstract: Preparation of 4-hydroxy substituted butyrolactones is described. A process for the preparation of 3-hydroxybutyrolactone, 1.2.4-trihydroxybutane and 3,4-dihydroxy acid methyl ester from malic acid is particularly described. The preparation of 4-hydroxymethyl-4-hydroxybutyric acid -1-methyl ester and 4-hydroxymethyl butyrolactone is particularly described. The compounds are intermediates to various pharmaceutical and agricultural products.
Type:
Grant
Filed:
March 28, 2002
Date of Patent:
November 18, 2003
Assignee:
Board of Trustees of Michigan State University